BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 181657)

  • 1. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
    Hazzard WR; Bierman EL
    Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
    Hazzard ER; Bierman EL
    J Lab Clin Med; 1975 Aug; 86(2):239-52. PubMed ID: 168277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-beta disease versus endogenous hypertriglyceridemia: levels and lipid composition of chylomicrons and very low density lipoproteins during fat-free feeding and alimentary lipemia.
    Hazzard WR; Bierman EL
    Metabolism; 1975 Jul; 24(7):817-28. PubMed ID: 166269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.
    Karpe F; Hellénius ML; Hamsten A
    Metabolism; 1999 Mar; 48(3):301-7. PubMed ID: 10094104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.
    Björkegren J; Karpe F; Milne RW; Hamsten A
    J Lipid Res; 1998 Jul; 39(7):1412-20. PubMed ID: 9684744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women.
    Berr F; Eckel RH; Kern F
    J Lipid Res; 1986 Jun; 27(6):645-51. PubMed ID: 3746133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia.
    Fainaru M; Mahley RW; Hamilton RL; Innerarity TL
    J Lipid Res; 1982 Jul; 23(5):702-14. PubMed ID: 7119569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma very low density lipoprotein (VLDL) in cholesterol-fed rabbits: chylomicron remnants or liver lipoproteins?
    Thompson KH; Zilversmit DB
    J Nutr; 1983 Oct; 113(10):2002-10. PubMed ID: 6619979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway.
    Karpe F; Hultin M
    J Lipid Res; 1995 Jul; 36(7):1557-66. PubMed ID: 7595079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects.
    Björnson E; Packard CJ; Adiels M; Andersson L; Matikainen N; Söderlund S; Kahri J; Hakkarainen A; Lundbom N; Lundbom J; Sihlbom C; Thorsell A; Zhou H; Taskinen MR; Borén J
    J Intern Med; 2020 Oct; 288(4):422-438. PubMed ID: 31846520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.
    Wilson DE; Chan IF; Buchi KN; Horton SC
    Metabolism; 1985 Jun; 34(6):551-8. PubMed ID: 3999977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man.
    Redgrave TG; Carlson LA
    J Lipid Res; 1979 Feb; 20(2):217-29. PubMed ID: 220359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.
    Karpe F; Bell M; Björkegren J; Hamsten A
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):199-207. PubMed ID: 7749826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.
    Boquist S; Ruotolo G; Hellénius ML; Danell-Toverud K; Karpe F; Hamsten A
    Atherosclerosis; 1998 Apr; 137(2):391-400. PubMed ID: 9622282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.
    Brunzell JD; Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia).
    Hazzard WR; Porte D; Bierman EL
    J Clin Invest; 1970 Oct; 49(10):1853-8. PubMed ID: 5460288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids.
    Westphal S; Orth M; Ambrosch A; Osmundsen K; Luley C
    Am J Clin Nutr; 2000 Apr; 71(4):914-20. PubMed ID: 10731497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the composition and physico-chemical characteristics of serum lipoproteins during ethanol-induced lipaemia in alcoholic subjects.
    Avogaro P; Cazzolato G
    Metabolism; 1975 Nov; 24(11):1231-42. PubMed ID: 171538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of fasting plasma triglyceride levels: metabolism of hepatic and intestinal lipoproteins.
    Cortner JA; Le NA; Coates PM; Bennett MJ; Cryer DR
    Eur J Clin Invest; 1992 Mar; 22(3):158-65. PubMed ID: 1582440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.